Alnylam Pharmaceuticals
ALNY
#622
Rank
ยฃ26.10 B
Marketcap
ยฃ202.40
Share price
-1.16%
Change (1 day)
36.08%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company